Clinical Trial Update: Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and potential efficacy of CMD03 CAR T cells in pediatric patients with relapsed or refractory solid tumors; recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CMD03 CAR T Cell

Snippet

Sponsor: Chulalongkorn University | Conditions: Pediatric Cancers, Solid Tumor Pediatric | Phase 1 | Status: RECRUITING